Sanuwave provides wound care technologies that aim to restore the body's regenerative process with FDA cleared ultrasound systems for pain-free treatment.

Sanuwave

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Robert Walter

Cardinal Health, Inc.

Ethicon develops surgical technologies to aid in the healing process.

Ethicon

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Integra LifeSciences Holdings Corporation

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.

SANUWAVE Health, Inc.

SANUWAVE | 3,984 followers on LinkedIn. Heal Wounds With Energy First | As an emerging leader in the development and commercialization of energy transfer technology, SANUWAVE® presents products that help expedite wound healing on a cellular level. SANUWAVE’s easy-to-use ENERGY FIRST® product portfolio works to help heal some of the most difficult, stalled, or hard-to-heal wounds by activating the body’s normal regenerative process using an assortment of energy waves, from shockwaves to ultrasound.

SANUWAVE values patient comfort and the importance of wound healing, recognizing its’ value to not only improve patient quality of life but to help avoid further complications that could lead to amputation or even lives lost.

Founder/PM at Manchester Explorer Fund and CEO at Sanuwave Health Inc

Morgan Frank

Jeffrey Blizard

Chief Science and Technology Officer at Sanuwave, Inc.

Iulian Cioanta, Ph.D

Key Accounts Manager at Sanuwave, Inc.

Stephen Bird

SANUWAVE

"I am very passionate about serving our patients to the best of our ability. When i first heard about UltraMIST, I immediately became interested. After watching a few treatments, in a very short time the results began to show. Patients were happier, and that's when I became a believer." Ross McCollom - Director of Rehab, Millbrook Healthcare and Rehabilitation #UltraMIST #patientcare #ensign

Restore First Health in Savannah GA, is bringing UltraMIST home! (seriously) The team is focused on bringing the best possible outcomes to its patients, with a focused on in-home wound care. “UltraMIST offers a great way to provide wound care to our complicated patients wounds that may have contraindications or lack of healing response to the standard wound care therapies. The ability to heal their wounds means improvement in their quality of life.” Amanda Beckner – Restore First Health #UltraMIST #patientcare

Press Release: SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering https://lnkd.in/dZHR573j

October is designated by the American Physical Therapy Association (APTA) as National Physical Therapy Month. We are pleased to present this month's webinar, graciously sponsored by SANUWAVE with our speaker Dr. Stephanie Woelfel to discuss the importance of including physical therapy as a necessary component of wound management. You can click the link below to register and share with your network. #woundcare #woundhealing #physicaltherapy #choosePT #fallprevention #inGoodCommpany Register: https://lnkd.in/eMB34UsT

Association for the Advancement of Wound Care

The group at Ensign San Pedro Manor is excited to bring UltraMIST® to their patients in sunny San Antonio, TX. We love to see folks all smiles about patient care! #PatientCare #UltraMist

Come see Sanuwave at the Fall Symposium on Advanced Wound Care (SAWC) this week in Las Vegas, NV. Stop by Booth #314 to chat with our amazing team and learn more about how UltraMIST® can support your wound healing program. #SAWC #UltraMIST #woundcare #Sanuwave

Thank you to the team at Kern River Transitional Care in Bakersfield, CA. It was clear working with this group that they are passionate about improving patient care, and we are proud that UltraMIST is now a part of it! "UltraMIST allows our nursing and therapy teams to work hand in hand to promote healing and increase quality of life by tackling wounds that inhibit daily living and activities. This would be a great first step to allow our residents to regain the ability to be up more and really engage them during their stay here at Kern River Transitional Care. We are excited about the many opportunities this would allow for both patients and staff!" -Tai Ann Villaruz - Director of Rehabilitation, KRTC #UltraMIST #PatientCare

Great to work with the team at ReviveCare today to support them in bringing UltraMIST® to their patients in NJ. #UltraMIST #LetsHealTogether

We're #hiring a new Clinical Specialist - Medical Device in Texas. You can apply today or share this post with your network.

Metric
Company Name	Sanuwave	Cardinal Health, Inc.	Ethicon	Integra LifeSciences Holdings Corporation
Symbol		CAH		IART
MSH ID	COM:SANUWAVE	COM:CARDINALHEALTH	COM:ETHICON	COM:INTEGRALIFE
Market	STOCKS	STOCKS	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare	Healthcare & Health Services	Healthcare
Industry	Medical Devices	Medical - Distribution	Medical Devices	Medical - Devices
Country	US	US	US	US
Stage
Employee Count		47.04K		3.95K
Website	sanuwave.com	cardinalhealth.com	ethicon.com	integralife.com
LinkedIn	sanuwave
Founders

Metric
Market Cap	22.44M	23.28B	2.31B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	226.83B	1.54B
Revenue (LTM)
Revenue (NTM)
Gross Profit	7.41B	888.39M
EBITDA	1.24B	297.59M
Operating Income	1.24B	174.08M
Net Income	852M	67.74M
EPS	3.48	0.85
Diluted EPS	3.45	0.84
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.03	0.67
Operating Profit Margin	0.01	0.09
EBITDA Margin	0.01	0.19
Net Profit Margin	0.00	0.04
Return on Equity	-0.17	0.04
Return on Assets	0.02	0.02
Return on Capital Employed	0.17	0.04

COM:SANUWAVE

Sanuwave

Last Close

22.19

22/11 20:31

Market Cap

22.44M

Beta: -

Volume Today

8.52K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	39.78	32.01
P/B Ratio	-7.37	2.04
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.13	1.74
EV Multiple	9.86	16.24

Metric
Days Sales Outstanding	19.91	60.64
Days Payables Outstanding	59.85	53.84
Days Inventory Outstanding	32.24	293.69
Operating Cycle	52.14	351.22
Cash Conversion Cycle	-6.21	282.50
Asset Turnover	5.03	0.41

Metric
Operating Cash Flow	3.76B	139.96M
Free Cash Flow	3.25B	73.09M
Cash Flow to Debt	0.84	0.63
Operating Cash Flow/Sales	0.02	0.09
Free Cash Flow Yield	0.13	0.04

Metric
Cash & Equivalents	5.13B	276.40M
Accounts Receivable	-996M	4.59M
Inventory	14.96B	389.61M
Goodwill		1.06B
Debt to Capitalization	3.71	0.55
Debt to Assets	0.10	0.28
Current Ratio	0.98	2.89
Quick Ratio	0.56	3.35

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.00	0.01
R&D to Revenue		0.07
SG&A to Revenue